Padmanee ‘Pam’ Sharma, M.D., Ph.D.

Co-Director, Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center

Immunology, Immunotherapy, GU Medical Oncology

EDUCATION

BA - Boston University

MA - Boston University

MD/PhD - Pennsylvania State University College of Medicine

Residency - New York Presbyterian Hospital, Weill Cornell Medical Center

Postdoctoral Fellow - Memorial Sloan-Kettering Cancer Center

AWARDS AND ACCOLADES

MD Anderson Cancer Center Faculty Scholar Award

MD Anderson Cancer Center Emil Frei, III Award for Excellence in Translational Research

MD Anderson Cancer Center The Julie & Ben Rogers Award for Excellence in Research

William B. Coley Award in Tumor Immunology by the Cancer Research Institute

American Society for Clinical Investigation (ASCI)

Women in Science with Excellence (WISE) Honoree, BioHouston

COMPANIES AND BOARDS

Co-Founder: Apricity Health, Jounce Therapeutics (NASDAQ: JNCE), Agilicell

Scientific Advisory Board: Amgen, Astellas, Kite Pharma (acquired by Gilead), Jounce Therapeutics (NASDAQ: JNCE), Forty Seven, Inc., AstraZeneca Advisory Board, Bristol Myers Squibb Immunology Biomarker Advisory Board, GSK Biomarkers Advisory Board, Hummingbird Bioscience, BioMx, Dragonfly Therapeutics, Codiak Biosciences, Lava Therapuetics, Glympse Bio

MEMBER OF Investment Committee

Associated Portfolio Companies

No items found.